Perhaps read the last Her-vaxx trial ann. The IDMC (very expert, and FDA relevant decision makers) recommended stopping the trial early due it being unethical to continue trial patients on the current SoC - Her-vaxx was roughly twice as good in terms of OS, in a statistically significant way.
On top of an amazing safety profile.
IMHO, this is a hugely positive indication in any cancer trial, and for IMU.
The data seems to be in, what deal can be done with it?
Media Thread, page-681
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.4¢ |
Change
-0.003(3.45%) |
Mkt cap ! $614.8M | |||
| Open | High | Low | Value | Volume |
| 8.5¢ | 8.6¢ | 8.2¢ | $2.066M | 24.59M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 155713 | 8.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.4¢ | 140171 | 5 |
View Market Depth
| Last trade - 16.10pm 01/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.3¢ |
Change
-0.003 ( 4.16 %) |
||||
| Open | High | Low | Volume | ||
| 8.5¢ | 8.6¢ | 8.2¢ | 6789460 | ||
| Last updated 15.59pm 01/05/2024 ? | |||||
| IMU (ASX) Chart |